The phthalate ester di-(2-ethylhexyl) phthalate is extensively used as a plasticizer in polyvinyl chloride formulations, where it may constitute up to 40% of the weight of the finished product (Autian, 1973) . Di-(2-ethylhexyl) phthalate is widely distributed in the environment, having been detected in various forms of marine life (Mayer et al., 1972) , soil samples (Ogner & Schnitzer, 1970) and both animal (Nazir et al., 1971) and human (Jaeger & Rubin, 1972) tissues. Although a number of toxicological investigations into the effects of di-(2-ethylhexyl) phthalate have been conducted in various rodent species, relatively few investigations have been made in non-rodent species. In the context of assessing the use of the ferret as a non-rodent species for toxicological studies, we have investigated the hepatic effects produced by di-(2-ethylhexyl) phthalate administration to this animal.
The administration of a 1 % (w/w) di-(2-ethylhexyl) phthalate diet for a period of 14 months to male adult albino ferrets produced marked liver enlargement (Table 1) . However, the enzyme activities of succinate dehydrogenase (EC 1.3.99.1), aniline 4-hydroxylase and glucose 6-phosphatase (EC 3.1.3.9) were significantly decreased to 61,78 and 37 % of control values respectively. Histochemical examination of the livers of the di-(2-ethylhexyl) phthalate-treated ferrets revealed extensive losses of aniline 4-hydroxylase and glucose 6-phosphatase activities from groups of cells sited near the centrilobular area of the liver lobule. The depression of succinate dehydrogenase activity was observed in cells associated with both the centrilobular and mid-zonal areas of the liver lobule. Further, marked lysosomal disturbances were observed in the liver lobules of the phthalate-treated animals. These changes consisted of a loss of acid phosphatase (EC 3.1.3.2) activity from the centrilobular region with increased activity in the mid-zonal and periportal areas. Although there was no change in the microsomal cytochrome P-450 content, a small but statistically insignificant increase in the microsomal protein content was observed. Ultrastructural examination of liver cells from the di-(2-ethylhexyl) phthalate-treated ferrets revealed the presence of increased smooth endoplasmic reticulum, which appeared irregular in outline when compared with that of the control animals. Additionally, the numbers of Iysosomes were more numerous than in the controls, and autophagic vacuoles were frequently observed. We have also studied the metabolism of orally administered [~arbonyl-'~C]di-(2ethylhexyl) phthalate in the ferret. Analysis of the 14C-labelled metabolites in urine indicated that the phthalate diester was metabolized in the ferret to derivatives of mono-(2ethylhexyl) phthalate, neither phthalic acid nor mono-(2-ethylhexyl) phthalate being detected in the urine. These studies indicate that the administration of di-(2-ethylhexyl) phthalate to the male albino ferret is accompanied by a number of marked hepatic biochemical and morphological changes. Further, a number of similarities exist between the hepatic effects of dL(2-ethylhexyl) phthalate in the ferret and those observed after the short-term administration of the diester to the rat (Lake et al., 1975) . Additionally, in the rat, orally administered di-(2ethylhexyl) phthalate is known to be metabolized to derivatives of rnono-(2ethylhexyl) phthalate (Albro et al., 1973; Daniel & Bratt, 1974) , and that the hepatic effects of the diester are essentially reproducible by the administration of the monoester (Lake et al., 1975) .
Thus our findings show that di-(2-ethylhexyl) phthalate may be considered hepatotoxic in both the rat and the ferret. This similarity in effect may be because the diester is metabolized to derivatives of the monoester in both species.
